Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07432633 · ClinicalTrials.gov registry record · Phase 1
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
A Phase 1 study of Colorectal Cancer and Gastric Cancer, sponsored by Blue Earth Diagnostics.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT07432633: Recruiting Phase 1 study of Colorectal Cancer and Gastric Cancer, sponsored by Blue Earth Diagnostics.
NCT07432633 is a Phase 1 study of Colorectal Cancer and Gastric Cancer that is actively recruiting participants, run by Blue Earth Diagnostics. The registered enrollment target is 71 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07432633, a Phase 1 study of Colorectal Cancer and Gastric Cancer, is actively recruiting participants, sponsored by Blue Earth Diagnostics.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multi-center, open-label, single-arm, Phase 1/2 study designed to evaluate the safety, radiation dosimetry, and preliminary diagnostic performance of \[18F\]FPyQCP in detecting colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
Primary Outcome
Whole body effective dose of a single dose of \[18F\]FPyQCP
Conditions Studied
Interventions
- DRUG [18F]FPyQCP
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2026-01-31 |
| Est. Completion | 2028-01-31 |
| Phase | Phase 1 |
What NCT07432633 shows while recruiting
NCT07432633 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (95% lower).
The record links to 5 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which [18F]FPyQCP is the first listed.
NCT07432633 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07432633 about?
NCT07432633 is a clinical study titled "[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications". This is a multi-center, open-label, single-arm, Phase 1/2 study designed to evaluate the safety, radiation dosimetry, and preliminary diagnostic performance of \[18F\]FPyQCP in detecting colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast ca...
What is the current status of trial NCT07432633?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 71 participants. The study started on 2026-01-31. Estimated completion is 2028-01-31.
What conditions does trial NCT07432633 study?
This clinical trial studies the following conditions: Colorectal Cancer, Gastric Cancer, Pancreatic Ductal Adenocarcinoma, Epithelial Ovarian Cancer, Invasive Lobular Breast Carcinoma.
What interventions are being tested in trial NCT07432633?
The interventions under investigation include: [18F]FPyQCP (DRUG).
Who is sponsoring clinical trial NCT07432633?
This trial is sponsored by Blue Earth Diagnostics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07432633 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07432633's enrollment target sits among peer trials
71 242nd of 381 higher than 139 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RECRUITING · Phase 1
-
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RECRUITING · Phase 1
-
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
RECRUITING · Phase 1
-
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RECRUITING · Phase 1
-
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI